Your browser doesn't support javascript.
loading
Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration-resistant prostate cancer: AFTERCAB study.
Uemura, Hiroji; Kobayashi, Kazuki; Yokomizo, Akira; Hinotsu, Shiro; Horie, Shigeo; Kakehi, Yoshiyuki; Naito, Seiji; Nonomura, Norio; Ogawa, Osamu; Oya, Mototsugu; Suzuki, Kazuhiro; Saito, Atsushi; Uno, Satoshi; Akaza, Hideyuki.
Affiliation
  • Uemura H; Yokohama City University Medical Center Yokohama Japan.
  • Kobayashi K; Yokosuka Kyosai Hospital Yokosuka Japan.
  • Yokomizo A; Harasanshin Hospital Fukuoka Japan.
  • Hinotsu S; Sapporo Medical University Sapporo Japan.
  • Horie S; Graduate School of Medicine Juntendo University Tokyo Japan.
  • Kakehi Y; Department of Urology National University Corporation Kagawa University Takamatsu Japan.
  • Naito S; Harasanshin Hospital Fukuoka Japan.
  • Nonomura N; Graduate School of Medicine Osaka University Osaka Japan.
  • Ogawa O; Graduate School of Medicine Kyoto University Kyoto Japan.
  • Oya M; School of Medicine Keio University Tokyo Japan.
  • Suzuki K; Graduate School of Medicine Gunma University Maebashi Japan.
  • Saito A; Astellas Pharma Inc. Tokyo Japan.
  • Uno S; Astellas Pharma Inc. Tokyo Japan.
  • Akaza H; Department of Strategic Investigation on Comprehensive Cancer Network, Research Center for Advanced Science and Technology The University of Tokyo Tokyo Japan.
BJUI Compass ; 3(1): 26-36, 2022 Jan.
Article in En | MEDLINE | ID: mdl-35475157
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: BJUI Compass Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: BJUI Compass Year: 2022 Document type: Article Country of publication: